Seeing Is Believing

Currently out of the existing stock ratings of Dae Gon Ha, 117 are a BUY (82.39%), 25 are a HOLD (17.61%).
Analyst Dae Gon Ha, carries an average stock price target met ratio of 38.05% that have a potential upside of 36% achieved within 127 days. Previously, Dae Gon Ha worked at STIFEL, BTIG, LEERINK.
Dae Gon Ha’s has documented 255 price targets and ratings displayed on 31 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on FULC, Fulcrum Therapeutics at 08-Dec-2025.
Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 6/17/2022. The price target of $25 was fulfilled within 59 days with a profit of $21.06 (534.52%) receiving and performance score of 90.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Feb-2022
$60
2 years 9 months 24 days ago
(18-Dec-2023)
0/2 (0%)
$60 (0.00%)
$2.04
$0.64 (45.71%)
$36
3 years 2 months 29 days ago
(13-Jul-2023)
0/2 (0%)
$2.04 (0.00%)
$2.04
$0.64 (45.71%)
$32
3 years 3 months ago
(12-Jul-2023)
0/3 (0%)
$2.04 (0.00%)
$6
$4.6 (328.57%)
$6
3 years 6 months 18 days ago
(24-Mar-2023)
0/5 (0%)
$6 (0.00%)
Hold Since 08-Dec-2022
$4
3 years 10 months 4 days ago
(08-Dec-2022)
0/3 (0%)
$4 (0.00%)